Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Lewsley LA"'
Autor:
Millstein, J, Budden, T, Goode, EL, Anglesio, MS, Talhouk, A, Intermaggio, MP, Leong, HS, Chen, S, Elatre, W, Gilks, B, Nazeran, T, Volchek, M, Bentley, RC, Wang, C, Chiu, DS, Kommoss, S, Leung, SCY, Senz, J, Lum, A, Chow, V, Sudderuddin, H, Mackenzie, R, George, J, AOCS Group, Fereday, S, Hendley, J, Traficante, N, Steed, H, Koziak, JM, Köbel, M, McNeish, IA, Goranova, T, Ennis, D, Macintyre, G, Silva De Silva, D, Ramón Y Cajal, T, García-Donas, J, Hernando Polo, S, Rodriguez, GC, Cushing-Haugen, KL, Harris, HR, Greene, CS, Zelaya, RA, Behrens, S, Fortner, RT, Sinn, P, Herpel, E, Lester, J, Lubiński, J, Oszurek, O, Tołoczko, A, Cybulski, C, Menkiszak, J, Pearce, CL, Pike, MC, Tseng, C, Alsop, J, Rhenius, V, Song, H, Jimenez-Linan, M, Piskorz, AM, Gentry-Maharaj, A, Karpinskyj, C, Widschwendter, M, Singh, N, Kennedy, CJ, Sharma, R, Harnett, PR, Gao, B, Johnatty, SE, Sayer, R, Boros, J, Winham, SJ, Keeney, GL, Kaufmann, SH, Larson, MC, Luk, H, Hernandez, BY, Thompson, PJ, Wilkens, LR, Carney, ME, Trabert, B, Lissowska, J, Brinton, L, Sherman, ME, Bodelon, C, Hinsley, S, Lewsley, LA, Glasspool, R, Banerjee, SN, Stronach, EA, Haluska, P, Ray-Coquard, I, Mahner, S, Winterhoff, B, Slamon, D, Levine, DA, Kelemen, LE, Benitez, J, Chang-Claude, J
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology, vol 31, iss 9
BackgroundMedian overall survival (OS) for women with high-grade serous ovarian cancer (HGSOC) is ∼4 years, yet survival varies widely between patients. There are no well-established, gene expression signatures associated with prognosis. The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::af2ade2cd37beaef06d324cec9ddbdab
https://escholarship.org/uc/item/08f3w53b
https://escholarship.org/uc/item/08f3w53b
Autor:
Goranova, T, Ennis, D, Piskorz, AM, Macintyre, G, Lewsley, LA, Stobo, J, Wilson, C, Kay, D, Glasspool, RM, Lockley, M, Brockbank, E, Montes, A, Walther, A, Sundar, S, Edmondson, R, Hall, GD, Clamp, A, Gourley, C, Hall, M, Fotopoulou, C, Gabra, H, Freeman, S, Moore, L, Jimenez-Linan, M, Paul, J, Brenton, JD, McNeish, IA, BriTROC investigators
Publikováno v:
British Journal of Cancer
Investigating tumour evolution and acquired chemotherapy resistance requires analysis of sequential tumour material. We describe the feasibility of obtaining research biopsies in women with relapsed ovarian high-grade serous carcinoma (HGSC).Women wi
Autor:
Millstein, J, Budden, T, Goode, EL, Anglesio, MS, Talhouk, A, Intermaggio, MP, Leong, HS, Chen, S, Elatre, W, Gilks, B, Nazeran, T, Volchek, M, Bentley, RC, Wang, C, Chiu, DS, Kommoss, S, Leung, SCY, Senz, J, Lum, A, Chow, V, Sudderuddin, H, Mackenzie, R, George, J, AOCS Group, Fereday, S, Hendley, J, Traficante, N, Steed, H, Koziak, JM, Köbel, M, McNeish, IA, Goranova, T, Ennis, D, Macintyre, G, Silva De Silva, D, Ramón Y Cajal, T, García-Donas, J, Hernando Polo, S, Rodriguez, GC, Cushing-Haugen, KL, Harris, HR, Greene, CS, Zelaya, RA, Behrens, S, Fortner, RT, Sinn, P, Herpel, E, Lester, J, Lubiński, J, Oszurek, O, Tołoczko, A, Cybulski, C, Menkiszak, J, Pearce, CL, Pike, MC, Tseng, C, Alsop, J, Rhenius, V, Song, H, Jimenez-Linan, M, Piskorz, AM, Gentry-Maharaj, A, Karpinskyj, C, Widschwendter, M, Singh, N, Kennedy, CJ, Sharma, R, Harnett, PR, Gao, B, Johnatty, SE, Sayer, R, Boros, J, Winham, SJ, Keeney, GL, Kaufmann, SH, Larson, MC, Luk, H, Hernandez, BY, Thompson, PJ, Wilkens, LR, Carney, ME, Trabert, B, Lissowska, J, Brinton, L, Sherman, ME, Bodelon, C, Hinsley, S, Lewsley, LA, Glasspool, R, Banerjee, SN, Stronach, EA, Haluska, P, Ray-Coquard, I, Mahner, S, Winterhoff, B, Slamon, D, Levine, DA, Kelemen, LE, Benitez, J, Chang-Claude, J, Gronwald, J, Wu, AH, Menon, U, Goodman, MT, Schildkraut, JM, Wentzensen, N, Brown, R, Berchuck, A, Chenevix-Trench, G, DeFazio, A, Gayther, SA, García, MJ, Henderson, MJ, Rossing, MA, Beeghly-Fadiel, A, Fasching, PA, Orsulic, S, Karlan, BY, Konecny, GE, Huntsman, DG, Bowtell, DD, Brenton, JD, Doherty, JA, Pharoah, PDP, Ramus, SJ
BACKGROUND: Median overall survival (OS) for women with high-grade serous ovarian cancer (HGSOC) is ∼4 years, yet survival varies widely between patients. There are no well-established, gene expression signatures associated with prognosis. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74bdd0831511aa30c41cb97076462cf9
Autor:
Smith P; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Bradley T; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Gavarró LM; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Goranova T; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Ennis DP; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Mirza HB; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., De Silva D; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Piskorz AM; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Sauer CM; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Al-Khalidi S; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Funingana IG; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Reinius MAV; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Giannone G; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Lewsley LA; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Stobo J; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., McQueen J; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Bryson G; Department of Histopathology, Queen Elizabeth University Hospital, Glasgow, UK., Eldridge M; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Macintyre G; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.; Centro Nacional de Investigaciones Oncológicas, Madrid, Spain., Markowetz F; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Brenton JD; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK. james.brenton@cruk.cam.ac.uk.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. james.brenton@cruk.cam.ac.uk., McNeish IA; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK. i.mcneish@imperial.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2023 Sep 26; Vol. 14 (1), pp. 5992. Date of Electronic Publication: 2023 Sep 26.
Autor:
Corbaux P; EA UCBL/HCL 3738, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, Lyon, France; Medical Oncology, Institut de Cancérologie et d'Hématologie Universitaire de Saint-Étienne (ICHUSE), Centre Hospitalier Universitaire de Saint-Etienne, France., You B; EA UCBL/HCL 3738, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, Lyon, France; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, Centre Hospitalier Lyon-Sud, GINECO, GINEGEPS, Lyon, France. Electronic address: benoit.you@chu-lyon.fr., Glasspool RM; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, UK., Yanaihara N; Department of Obstetrics and Gynecologye, The Jikei University School of Medicine, Tokyo, Japan., Tinker AV; Medical Oncology, BC Cancer - Vancouver, Vancouver, Canada., Lindemann K; Department of Gynaecological Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Ray-Coquard IL; Medical Oncology Department, Centre Léon Bérard, GINECO, Lyon, France., Mirza MR; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Clinical Trial Unit, Nordic Society of Gynaecological Oncology, Copenhagen, Denmark., Subtil F; Department of Biostatistics, Hospices Civils de Lyon, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, CNRS UMR 5558, Claude Bernard University Lyon 1, Lyon, France., Colomban O; EA UCBL/HCL 3738, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, Lyon, France., Péron J; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, Centre Hospitalier Lyon-Sud, GINECO, GINEGEPS, Lyon, France; Department of Biostatistics, Hospices Civils de Lyon, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, CNRS UMR 5558, Claude Bernard University Lyon 1, Lyon, France., Karamouza E; Institut Gustave Roussy, Office of Biostatistics and Epidemiology, Université Paris-Saclay, Villejuif, France; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labelled Ligue Contre le Cancer, Villejuif, France., McNeish I; Department of Surgery and Cancer, Imperial College London, London, UK., Kelly C; Cancer Research UK Clinical Trial Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Kagimura T; Foundation for Biomedical Research and Innovation at Kobe, Translational Research Center for Medical Innovation, Kobe, Japan., Welch S; Department of Oncology, London Health Sciences Centre, London, Ontario, Canada., Lewsley LA; Cancer Research UK Clinical Trial Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Paoletti X; Institut Curie, St Cloud, France., Cook A; Medical Research Council Clinical Trials Unit, University College London, London, UK.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Sep; Vol. 191, pp. 112966. Date of Electronic Publication: 2023 Jul 04.
Autor:
Smith P; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Bradley T; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Gavarró LM; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Goranova T; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Ennis DP; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Mirza HB; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., De Silva D; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Piskorz AM; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Sauer CM; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Al-Khalidi S; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Funingana IG; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Reinius MAV; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Giannone G; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Lewsley LA; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Stobo J; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., McQueen J; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Bryson G; Department of Histopathology, Queen Elizabeth University Hospital, Glasgow, UK., Eldridge M; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Macintyre G; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.; Centro Nacional de Investigaciones Oncológicas, Madrid, Spain., Markowetz F; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Brenton JD; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK. james.brenton@cruk.cam.ac.uk.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. james.brenton@cruk.cam.ac.uk., McNeish IA; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK. i.mcneish@imperial.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2023 Jul 20; Vol. 14 (1), pp. 4387. Date of Electronic Publication: 2023 Jul 20.
Autor:
Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies, Institute of Cancer Research, London, United Kingdom., Giannone G; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, United Kingdom., Clamp AR; The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom., Ennis DP; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, United Kingdom., Glasspool RM; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Herbertson R; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, United Kingdom., Krell J; Medical Oncology, Imperial College Healthcare NHS Trust, London, United Kingdom., Riisnaes R; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom., Mirza HB; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, United Kingdom., Cheng Z; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, United Kingdom., McDermott J; Department of Histopathology, Imperial College Healthcare NHS Trust, London, United Kingdom., Green C; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Kristeleit RS; Research Department of Oncology, UCL Cancer Institute, University College London, London, United Kingdom.; Now with Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., George A; Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Gourley C; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, United Kingdom., Lewsley LA; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Rai D; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Banerji U; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom., Hinsley S; CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., McNeish IA; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, United Kingdom.; Medical Oncology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Publikováno v:
JAMA oncology [JAMA Oncol] 2023 May 01; Vol. 9 (5), pp. 675-682.
Autor:
Karamouza E; Gustave Roussy, Office of Biostatistics and Epidemiology, Université Paris-Saclay, 94805 Villejuif, France.; Oncostat, Labeled Ligue Contre le Cancer, CESP U1018, Inserm, Université Paris-Saclay, 94805 Villejuif, France., Glasspool RM; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow G12 0XH, UK., Kelly C; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow G12 0YN, UK., Lewsley LA; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow G12 0YN, UK., Carty K; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow G12 0YN, UK., Kristensen GB; Department of Gynecologic Oncology, Institute for Cancer Genetics and Informatics, Oslo University Hospital, 0424 Oslo, Norway., Ethier JL; Department of Medical Oncology, Cancer Centre of Southeastern Ontario, Queen's University, Kingston, ON K7L 3N6, Canada., Kagimura T; Foundation for Biomedical Research and Innocation, Translational Research Center for Medical Innovation, Kobe 650-0047, Japan., Yanaihara N; School of Medicine, The Jikei University, Tokyo 105-8461, Japan., Cecere SC; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., You B; EMR UCBL/HCL 3738, Faculté de Médecine Lyon-Sud, Université Lyon, Université Claude Bernard Lyon 1, 69100 Lyon, France.; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, Centre Hospitalier Lyon-Sud, GINECO, GINEGEPS, 69495 Lyon, France., Boere IA; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands., Pujade-Lauraine E; ARCAGY-GINECO, GINECO, GINEGEPS, 75008 Paris, France., Ray-Coquard I; Centre Léon Bérard, GINECO, 69008 Lyon, France., Proust-Lima C; UMR1219, Bordeaux Population Health Research Center, Inserm, University of Bordeaux, 33000 Bordeaux, France., Paoletti X; Faculty of Medicine, University of Versailles Saint-Quentin, Université Paris Saclay, 78000 Versailles, France.; INSERM U900, Statistics for Personalized Medicine, Institut Curie, 92210 Saint-Cloud, France.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Mar 17; Vol. 15 (6). Date of Electronic Publication: 2023 Mar 17.
Autor:
Hanna CR; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK. Catherine.hanna@glasgow.ac.uk., O'Cathail SM; Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, 1053 Great Western Road, Glasgow, G12 0YN, UK., Graham JS; Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, 1053 Great Western Road, Glasgow, G12 0YN, UK., Saunders M; The Christie NHS Foundation Trust, Wilmslow Rd, Manchester, M20 4BX, UK., Samuel L; Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN, UK., Harrison M; Mount Vernon Cancer Centre, Rickmansworth Rd, Northwood, HA6 2RN, UK., Devlin L; Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 0YN, UK., Edwards J; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, G61 1QH, UK., Gaya DR; Gastroenterology Unit, Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde, 4th Floor Walton Building, Castle Street, Glasgow, G4 0SF, UK., Kelly CA; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK., Lewsley LA; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK., Maka N; Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, 1345 Govan Road, Glasgow, G51 4TF, UK., Morrison P; Snr Pharmacist Clinical Trials Oncology R&I, Research and Innovation, Dykebar Hospital, NHS Greater Glasgow and Clyde, Ward 11, Grahamston Road, Paisley, PA2 7DE, UK., Dinnett L; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK., Dillon S; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK., Gourlay J; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK., Platt JJ; Department of Radiology, NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, UK., Thomson F; Institute of Cancer Sciences, University of Glasgow, Glasgow, G61 1QH, UK., Adams RA; Centre for Trials Research Cardiff University Heath Park, Cardiff University and Velindre NHS Trust, Cardiff, UK., Roxburgh CSD; Institute of Cancer Sciences, Glasgow Royal Infirmary, University of Glasgow, Room 2.57, Level 2, New Lister Building, Glasgow, G31 2ER, UK.
Publikováno v:
Radiation oncology (London, England) [Radiat Oncol] 2021 Dec 02; Vol. 16 (1), pp. 230. Date of Electronic Publication: 2021 Dec 02.
Autor:
Hanna CR; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK. Catherine.hanna@glasgow.ac.uk., O'Cathail SM; Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, 1053 Great Western Road, Glasgow, G12 0YN, UK., Graham JS; Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, 1053 Great Western Road, Glasgow, G12 0YN, UK., Saunders M; The Christie NHS Foundation Trust, Wilmslow Rd, Manchester, M20 4BX, UK., Samuel L; Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN, UK., Harrison M; Mount Vernon Cancer Centre, Rickmansworth Rd, Northwood, HA6 2RN, UK., Devlin L; Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 0YN, UK., Edwards J; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, G61 1QH, UK., Gaya DR; Gastroenterology Unit, Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde, 4th Floor Walton Building, Castle Street, Glasgow, G4 0SF, UK., Kelly CA; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK., Lewsley LA; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK., Maka N; Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, 1345 Govan Road, Glasgow, G51 4TF, UK., Morrison P; Snr Pharmacist Clinical Trials Oncology R&I, Research & Innovation, Dykebar Hospital, NHS Greater Glasgow & Clyde, Ward 11, Grahamston Road, Paisley, PA2 7DE, UK., Dinnett L; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK., Dillon S; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK., Gourlay J; Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK., Platt JJ; Department of Radiology, NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, UK., Thomson F; Institute of Cancer Sciences, University of Glasgow, Glasgow, G61 1QH, UK., Adams RA; Centre for Trials Research Cardiff University Heath Park, Cardiff University and Velindre NHS Trust, Cardiff, UK., Roxburgh CSD; Institute of Cancer Sciences, Glasgow Royal Infirmary, University of Glasgow, Room 2.57, Level 2, New Lister Building, Glasgow, G31 2ER, UK.
Publikováno v:
Radiation oncology (London, England) [Radiat Oncol] 2021 Aug 26; Vol. 16 (1), pp. 163. Date of Electronic Publication: 2021 Aug 26.